Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy

J Chemother. 2009 Feb;21(1):101-4. doi: 10.1179/joc.2009.21.1.101.

Authors

G Braccini¹, I Lori, A S Neri, F Festini, I Pela, R Ciuti, V Boni, L Zavataro, C Braggion, M De Martino, G Taccetti

Affiliation

¹ Deparment of Pediatrics, University of Florence, Italy.

PMID: 19297282
DOI: 10.1179/joc.2009.21.1.101

No abstract available

MeSH terms

Adolescent
Adult
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / adverse effects*
Anti-Bacterial Agents / blood
Child
Cochlea / drug effects
Cystic Fibrosis / complications
Cystic Fibrosis / drug therapy*
Female
Gram-Negative Bacterial Infections / drug therapy*
Gram-Negative Bacterial Infections / etiology
Hearing Loss / chemically induced
Humans
Infusions, Parenteral
Kidney / drug effects
Male
Tobramycin / administration & dosage*
Tobramycin / adverse effects*
Tobramycin / blood

Substances

Anti-Bacterial Agents
Tobramycin